A former Arby’s manager in Oklahoma has been arrested after she allegedly infected a customer and her family with oral herpes ...

Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal fourth ...

A former Arby's manager in Oklahoma is facing criminal charges and a civil lawsuit after allegedly spitting into a customer's ...

Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...

An Oklahoma woman sues Arby's after allegedly contracting herpes from a contaminated sandwich. The lawsuit follows a ...

Arby's Customer Sues Store Manager After Allegedly Contaminated Sandwich Left Her With a Lifelong Viral Infection ...

Down 32% from all-time highs, TerraVest is a TSX dividend stock that offers you significant upside potential in June 2026.

Pediatric hospital medicine is rapidly advancing with new research focusing on clinical management, quality improvement, health equity, and technology. This summary highlights the top articles from ...

One of the most recurring issues in construction contracts, typically in public-works contracts, is the validity of ‘no-claim ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food and Drug Administration ...

CESTAT observed that the appellant executed complete government construction projects on a turnkey basis and was responsible for all aspects of implementation. Since the contracts were composite works ...